John McGinniss

8PUBLICATIONS
21CO-AUTHORS
Gene and molecular therapyMicrobial ecologyMedical microbiology not elsewhere classifiedPsychophysiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 25, 2026
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: a multicenter, randomized, double-blind, phase 3A clinical trial (NIMBLE).

Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch

|Mar 27, 2024
Definitions of Dysbiosis in Chronic Lung Allograft Dysfunction and High Bacterial Biomass.

John McGinniss

|Aug 01, 2023
Shifting the Overton Window on Nontuberculous Mycobacterial Disease Infection Susceptibility by Race.

John E McGinniss

|Sep 14, 2022
The Lung Allograft Microbiome Associates with Pepsin, Inflammation, and Primary Graft Dysfunction.

John E McGinniss, Samantha A Whiteside, Rebecca A Deek

|Nov 08, 2021
The Upper Airway Microbiome and Lung Injury in COVID-19.

John E McGinniss, Ronald G Collman

|Jun 27, 2020
Pearls & Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19.

Catherine V Kulick-Soper, Jillian L McKee, Ronald L Wolf

Pageof 2